FTSE 100 Modestly Higher On Fed Rate Cut Hopes

Canadian Market Looks Headed For Weak Close; Energy Stocks Fall

The Canadian market is down firmly in negative territory Monday afternoon with energy stocks reeling under sustained selling pressure on weak oil prices. A few stocks from healthcare and industrials sectors are also sharply lower.

RTTNews | 5h 57min ago

U.S. Dollar Drops Amid Weak ISM Manufacturing PMI

The U.S. dollar moved down against its major counterparts in the New York session on Monday, following the release of weaker-than-expected ISM manufacturing PMI data for May.

RTTNews | 6h 42min ago

Swiss Market Ends Slightly Up

The Switzerland market slipped into negative territory in the final hour of the session on Monday, but managed to edge higher and finish with a slender gain as a few stocks held firm.

RTTNews | 7h 14min ago

European Stocks Close Broadly Higher

European markets closed largely higher on Monday with investors picking up stocks, looking ahead to the European Central Bank's monetary policy announcement due later in the week.

RTTNews | 7h 29min ago

US Construction Spending Logs Surprise Fall In April

US construction spending shrunk unexpectedly in April amid declines in both private and public construction, preliminary data from the U.S. Census Bureau showed Monday. Construction spending dipped 0.1 percent to $2,099.0 billion from the revised estimate of $2,101.5 billion in March. Spending was expected to grow 0.2 percent after a 0.2 percent decrease in March.

RTTNews | 8h 56min ago

U.S. Manufacturing Index Unexpectedly Edges Lower In May

Manufacturing activity in the U.S. unexpectedly contracted at a slightly faster rate in the month of May, according to a report released by the Institute for Supply Management on Monday.

RTTNews | 10h 8min ago

$Kite Says Tecartus Shows Prolonged OS In Adults With Refractory B-cell Acute Lymphoblastic Leukemia$

Kite Says Tecartus Shows Prolonged OS In Adults With Refractory B-cell Acute Lymphoblastic Leukemia

Kite, a Gilead Sciences, Inc. Company (GILD), announced Monday updated, four-year overall survival (OS) data from the pivotal ZUMA-3 study evaluating the CAR T-cell therapy Tecartus (brexucabtagene autoleucel) in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL).

RTTNews | 10h 13min ago

Dollar Edged Down Last Week Amidst Inline PCE Data

PCE-based inflation data from the U.S. that came in mostly along expected lines marginally dragged down the 6-currency Dollar Index during the week ended May 31.

RTTNews | 10h 30min ago

EURUSD	1.0901	GBPUSD	1.28034	AUDUSD	0.66875
USDJPY	156.08	USDCAD	1.36312	USDCHF	0.8958